Refluxassociated changes of the remant esophagus after esophagectomy and gastric interposition– Gastrointestinal Function Testing during long time follow up in patients with esophageal cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011123

Enrollment

Registered

2016-09-30

Start date

2016-10-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K21.0

Interventions

Group 1: Gastrointestinal Function Testing Using laryngopharyngeal PH Probe (Restech) and conventional esophageal pH monitoring (impedance).

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with esophagus carcinoma that underwent hybrid Ivor Lewis esophagectomy and that gave their written consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Patients will undergo 24-h laryngopharyngeal pH measurement (Restech)and intraluminal impedance pH-monitoring at the same time so that the relationship between the two techniques can be evaluated (for assessment of gastrointestinal function).	—

Secondary

Measure	Time frame
Also they will undergo a routine check-up program with a surveillance endoscopie. To evaluate the symptoms patients are asked to fill out a standardized questionnaire (GERD HRQL). When we collected all the data we can evaluate the relationship between the two different techniques and the symptoms of the patient.	—

Countries

Germany

Contacts

Public ContactHans Fuchs

Klinik und Poliklinik für Allgemein-, Viszeral- und TumorchirurgieUniklinik Köln

hans.fuchs@uk-koeln.de+49-221-478-4801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026